Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |